Page last updated: 2024-10-31

mitoxantrone and Salivary Gland Neoplasms

mitoxantrone has been researched along with Salivary Gland Neoplasms in 2 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Salivary Gland Neoplasms: Tumors or cancer of the SALIVARY GLANDS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, JW1
Qiu, WL1
He, RG1
Gedlicka, C1
Schüll, B1
Formanek, M1
Kornfehl, J1
Burian, M1
Knerer, B1
Selzer, E1
Scheithauer, W1
Kornek, GV1

Trials

1 trial available for mitoxantrone and Salivary Gland Neoplasms

ArticleYear
Mitoxantrone and cisplatin in recurrent and/or metastatic salivary gland malignancies.
    Anti-cancer drugs, 2002, Volume: 13, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Dise

2002

Other Studies

1 other study available for mitoxantrone and Salivary Gland Neoplasms

ArticleYear
[Verapamil enhancement of antitumor effect of mitoxantrone on ACC-2 cell line in vitro and in vivo].
    Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology, 1994, Volume: 29, Issue:5

    Topics: Animals; Carcinoma, Adenoid Cystic; DNA, Neoplasm; Drug Synergism; Female; Humans; Male; Mice; Mice,

1994